Related Experiment Videos
Iophendylate (pantopaque) and MR imaging of the spine
A K Anand1, S N Halthore, S Wani
1Long Island Diagnostic Imaging Center, Stony Brook, New York, NY 11790.
Computerized Radiology : Official Journal of the Computerized Tomography Society
|July 1, 1987
Abstract:
Residual iophendylate in the spinal subarachnoid space may closely resemble certain spinal canal tumors on MR imaging of the spine. A knowledge of the appearance on MR imaging scans of iophendylate is essential to differentiate it from spinal tumors.
Insights
Residual iophendylate in the spinal subarachnoid space can mimic spinal tumors on MR imaging. Understanding iophendylate
Area of Science:
- Radiology
- Neurology
- Medical Imaging
Background:
- Iophendylate, a contrast agent, was historically used for myelography.
- Its retention in the spinal subarachnoid space can occur post-procedure.
Observation:
- Residual iophendylate can present as a mass lesion on Magnetic Resonance (MR) imaging.
- This appearance can be mistaken for neoplastic or other pathological spinal tumors.
Findings:
- The characteristic MR imaging features of residual iophendylate are crucial for accurate diagnosis.
- Differentiating iophendylate from actual spinal tumors requires careful evaluation of imaging characteristics.
Implications:
- Accurate differentiation prevents misdiagnosis and unnecessary invasive procedures.
- Knowledge of iophendylate's MR appearance aids radiologists in interpreting spinal imaging studies.
- This understanding is vital for appropriate patient management and treatment planning.